JY
AYTU icon

Jeff Yass’s AYTU BioPharma AYTU Stock Holding History

Jeff Yass’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-815
Closed -$22K – 12959
2021
Q4 		$22K Sell
815
-2,685
-77% -$116K ﹤0.01% 12807
2021
Q3 		$202K Sell
3,500
-2,990
-46% -$224K ﹤0.01% 11459
2021
Q2 		$650K Buy
6,490
+5,640
+664% +$662K ﹤0.01% 8920
2021
Q1 		$129K Buy
+850
New +$135K ﹤0.01% 11733

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $413M AUM 109.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jeff Yass's AYTU Position: Q2 2025 in Review

Jeff Yass sold out of AYTU BioPharma (AYTU) in Q2 2025, closing a stake of 14,865 shares — an estimated $17.8K sold.

Jeff Yass first reported a position in AYTU in Q1 2018 and held it in 10 quarters. The position peaked at $516K in Q2 2021. 32 funds tracked by Wall St. Rank hold AYTU as of Q2 2025.

  • Jeff Yass reported no remaining AYTU BioPharma position as of Q2 2025 after selling out during the quarter.
  • Jeff Yass sold 14,865 AYTU BioPharma shares in Q2 2025, an estimated $17.8K.
  • Jeff Yass first reported a position in AYTU BioPharma in Q1 2018 and held it in 10 quarters.
  • Jeff Yass's AYTU BioPharma position peaked at $516K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.